Alteogen Inc. Alteogen Inc.

Alteogen Inc.

196170

Rang in Aktien #1858
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters,... ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the development of ALT-P7, a targeted breast/gastric cancer drug that is in the Phase I clinical trial; ALT-Q5, an antibody-drug conjugate (ADC) for the treatment of ovarian cancer based on its NexMab ADC technology; and ALT-LS2, a SC (subcutaneous) formulation of trastuzuamb for the treatment of breast and gastric cancer. The company has a strategic alliance with Kissei Pharmaceutical for the development of ALT-L9, a biosimilar of Eylea (Aflibercept) which is currently under Phase 1 trial; Cristalia for the development of ALT-L2, a biosimilar of Herceptin (Trastuzumab), a monoclonal antibody for the treatment of breast cancer, which is in the Phase II clinical trial; and Biogen Inc. to develop subcutaneous (SC) formulations of biologics utilizing ALT-B4. ALTEOGEN Inc. was founded in 2008 and is headquartered in Daejeon, South Korea.
Aktienkurs
$164.92
Marktkapitalisierung
$11.48B
Veränderung (1 Tag)
3.70%
Veränderung (1 Jahr)
-46.70%
Land
KR
Handel Alteogen Inc. (196170)

Kategorie

Healthcare
Aktien-Split-Historie für Alteogen Inc. (196170)
Die Aktie Alteogen Inc. (Symbol: 196170) durchlief insgesamt 5 Aktiensplits.
Der letzte Aktiensplit fand am Aug 05, 2026 statt.
Eine 196170-Aktie, die vor dem Dec 07, 2017 gekauft wurde, entspricht heute 1.2037037037037 196170-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2026-08-05 13:10 x1.3 x1.2037037037037
2022-10-25 6:5 x1.2 x0.92592592592593
2021-03-24 5:4 x1.25 x0.77160493827161
2020-07-23 10:9 x1.1111111111111 x0.61728395061728
2017-12-07 5:9 x0.55555555555556 x0.55555555555556
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL